The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
June 7th 2023
It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.
Despite Gaps in Use, Study Finds Individuals With Psychosocial, Structural Barriers More Likely to Use PrEPApril 26th 2023
Both barriers and facilitating factors, as well as a history of STIs, are associated with recent PrEP use among urban transgender women.
Pharmacists Report High Levels of Burnout, Resulting in Understaffing and Alternative Career PathsApril 26th 2023
Pharmacists were asked about their levels of burnout, drivers and symptoms of this burnout, and what steps their workplaces had taken to improve the issue.
Limitations on Reproductive Rights Makes Agonizing Decisions Even Harder for Pregnant Women With CancerApril 25th 2023
Even before the Dobbs ruling overturned country-wide reproductive rights, the oncology field was already facing a dearth of maternal care access challenges.
Study Finds Novel CAR T-cell Therapy Feasible, Safe in High-Risk NeuroblastomaApril 25th 2023
Six weeks after infusion of GD2-CART01, 9 of 27 patients (33%) with relapsed or refractory high-risk neuroblastoma had a complete response or maintained a complete response.
Study Finds No Significant Effect on Infusion Reactions, Cardiac Dysfunction When Switching from Trastuzumab to Biosimilar in HER2-Positive Breast CancerApril 24th 2023
Infusion reactions in the switching group did not occur with switching, but rather only with reference trastuzumab administration.
Tislelizumab Demonstrates Superior Overall Survival Compared With ChemotherapyApril 24th 2023
Efficacy and safety data for BeiGene’s therapy shows positive results for individuals with advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
Pharmacists Will Have a Very Important Role in Psychedelic Medicine for Patients With CancerApril 21st 2023
As psychedelic medicine comes further into cancer care, pharmacists will be an important part of the interdisciplinary team in screening and evaluating patients for suitability for psychedelic medicine.
Research Suggests Dexamethasone Could Benefit Patients Hospitalized with COVID-19April 21st 2023
All-cause inpatient mortality or discharge to hospice was lower for patients who received dexamethasone within 48 hours of either admission or escalation in oxygen support.
Pneumococcal Vaccine Candidate Shows Promise in Adults Aged 65 Years and OlderApril 20th 2023
VAX-24 is designed to prevent invasive pneumococcal disease and pneumonia, which can be most serious for infants, young children, older adults, and those with immune deficiencies or some chronic health conditions.
FDA Approves Polatuzumab Vedotin-piiq Plus R-CHP For Certain Types of Diffuse Large B-cell LymphomaApril 20th 2023
In a phase 3 trial, the risk of disease progression, relapse, or death was reduced by 27% with polatuzumab vedotin-piiq plus R-CHP compared with R-CHOP in adults with previously untreated diffuse large B-cell lymphoma or high-grade B-cell lymphoma.
After COVID-19 Disruptions, CDC Report Suggests Return to Pre-Pandemic RSV SeasonalityApril 19th 2023
Atypical respiratory syncytial virus epidemics may continue, and testing patients for multiple respiratory pathogens when indicated might be necessary.
Study: Link Seen Between Children Exposed to Opioids During Pregnancy, Chronic DiseasesApril 19th 2023
Analysis shows that babies of mothers who used drugs while pregnant were shorter at birth and weighed less during the breastfeeding stage compared with non-drug-exposed infants.